Serological evidence that dry heating of clotting factor concentrates prevents transmission of non-A, non-B hepatitis
- 1 January 1990
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 30 (1), 50-52
- https://doi.org/10.1002/jmv.1890300111
Abstract
A new test for antibodies specific for an agent causing non-A, non-B hepatitis (NANBH) was used to screen 45 children with coagulation disorders who received factor concentrates. It was found that the test results correlated with clinical evidence of NANBH and that heat treatment of concentrates (80°C for 72 hours) appears to have prevented transmission of NANBH.Keywords
This publication has 11 references indexed in Scilit:
- Safety trial of heated factor VIII concentrate (8Y).Archives of Disease in Childhood, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989
- An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B HepatitisScience, 1989
- VIRUS SAFETY OF SOLVENT/DETERGENT-TREATED ANTIHAEMOPHILIC FACTOR CONCENTRATEThe Lancet, 1988
- Reduced risk of non‐A, non‐B hepatitis after a first exposure to ‘wet heated’factor VIII concentrateBritish Journal of Haematology, 1987
- TRANSMISSION OF NON-A, NON-B HEPATITIS BY HEAT-TREATED FACTOR VIII CONCENTRATEThe Lancet, 1985
- High risk of non‐A non‐B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulinBritish Journal of Haematology, 1985
- Reduction in Risk of Hepatitis Transmission by Heat-Treatment of a Human Factor VIII ConcentrateThe Journal of Infectious Diseases, 1984
- Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients.BMJ, 1983
- Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre.BMJ, 1983